150 related articles for article (PubMed ID: 8752714)
21. Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation.
Baron F; Gothot A; Salmon JP; Hermanne JP; Pierard GE; Fillet G; Beguin Y
Br J Haematol; 2000 Dec; 111(3):745-53. PubMed ID: 11122133
[TBL] [Abstract][Full Text] [Related]
22. Pemphigus and hematologic malignancies: A population-based study of 11,859 patients.
Kridin K; Zelber-Sagi S; Comaneshter D; Batat E; Cohen AD
J Am Acad Dermatol; 2018 Jun; 78(6):1084-1089.e1. PubMed ID: 29198780
[TBL] [Abstract][Full Text] [Related]
23. Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres.
Pagano L; Fianchi L; Mele L; Girmenia C; Offidani M; Ricci P; Mitra ME; Picardi M; Caramatti C; Piccaluga P; Nosari A; Buelli M; Allione B; Cortelezzi A; Fabbiano F; Milone G; Invernizzi R; Martino B; Masini L; Todeschini G; Cappucci MA; Russo D; Corvatta L; Martino P; Del Favero A
Br J Haematol; 2002 May; 117(2):379-86. PubMed ID: 11972521
[TBL] [Abstract][Full Text] [Related]
24. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
[TBL] [Abstract][Full Text] [Related]
25. Incidence and pattern of liver involvement in haematological malignancies.
Walz-Mattmüller R; Horny HP; Ruck P; Kaiserling E
Pathol Res Pract; 1998; 194(11):781-9. PubMed ID: 9842637
[TBL] [Abstract][Full Text] [Related]
26. A case of treatment-related myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemotherapy with autologous stem cell transplantation for non-Hodgkin's lymphoma.
Jang GD; Kim SW; Suh CW; Kim EK; Bahng HS; Jeong YH; Park IG; Kim WK; Kim SH; Suh EJ; Park CJ; Ji HS; Lee JS
J Korean Med Sci; 2002 Aug; 17(4):555-9. PubMed ID: 12172056
[TBL] [Abstract][Full Text] [Related]
27. Multiple primary cancers associated with hematological malignancies.
Nagura E; Kawashima K; Yamada K
Jpn J Clin Oncol; 1985 Apr; 15 Suppl 1():211-22. PubMed ID: 4009983
[TBL] [Abstract][Full Text] [Related]
28. [Current status and future perspective of new drugs for hematological malignancies in Japan].
Ogura M
Rinsho Ketsueki; 2007 Oct; 48(10):1442-52. PubMed ID: 17933133
[No Abstract] [Full Text] [Related]
29. Behcet's disease associated with malignancy: a report of 41 Chinese cases.
Lin Y; Li G; Zheng W; Tian X; Zhang F
Int J Rheum Dis; 2014 May; 17(4):459-65. PubMed ID: 24354961
[TBL] [Abstract][Full Text] [Related]
30. Simultaneous occurrence of multiple myeloma and chronic myeloid leukemia.
Alvarez-Larrán A; Rozman M; Cervantes F
Haematologica; 2001 Aug; 86(8):894. PubMed ID: 11524262
[No Abstract] [Full Text] [Related]
31. Disturbed expression of the anti-apoptosis gene, survivin, and EPR-1 in hematological malignancies.
Shinozawa I; Inokuchi K; Wakabayashi I; Dan K
Leuk Res; 2000 Nov; 24(11):965-70. PubMed ID: 11086180
[TBL] [Abstract][Full Text] [Related]
32. Wilms' Tumor Gene 1 (WT1) Peptide Vaccine Therapy for Hematological Malignancies: From CTL Epitope Identification to Recent Progress in Clinical Studies Including a Cure-Oriented Strategy.
Oka Y; Tsuboi A; Nakata J; Nishida S; Hosen N; Kumanogoh A; Oji Y; Sugiyama H
Oncol Res Treat; 2017; 40(11):682-690. PubMed ID: 29041012
[TBL] [Abstract][Full Text] [Related]
33. Survival in multiple myeloma patients who develop second malignancies: a population-based cohort study.
Jonsdottir G; Lund SH; Björkholm M; Turesson I; Wahlin A; Mailankody S; Blimark C; Hultcrantz M; Porwit A; Landgren O; Kristinsson SY
Haematologica; 2016 Apr; 101(4):e145-8. PubMed ID: 26681760
[No Abstract] [Full Text] [Related]
34. Chemotherapy during Pregnancy: Cases of Hodgkin's and Non-Hodgkin's Lymphoma, Chronic Myeloid Leukemia, Breast Cancer, Nasopharyngeal Cancer, and Choriocarcinoma.
Beksac K; Orgul G; Ozyuncu O; Yurdakok M; Altundag K; Beksac MS
Oncol Res Treat; 2017; 40(7-8):441-445. PubMed ID: 28700986
[TBL] [Abstract][Full Text] [Related]
35. Risk of Hematologic Malignancies in Elderly Patients With Ankylosing Spondylitis: A Cohort Study and Systematic Review.
Alehashemi S; Ward MM
Mayo Clin Proc; 2023 Jan; 98(1):100-110. PubMed ID: 36470752
[TBL] [Abstract][Full Text] [Related]
36. [In-vitro change in CFU-GM in chronic myeloid leukemia and myelodysplastic syndromes. Its implication in the dysfunction of the hematologic barrier].
Gronda M; Malka A; Demattei A; Elizalde P; Santarelli MT; Bianchi de Di Risio CC
Sangre (Barc); 1988 Aug; 33(4):277-81. PubMed ID: 3187844
[No Abstract] [Full Text] [Related]
37. Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma.
Travis LB; Weeks J; Curtis RE; Chaffey JT; Stovall M; Banks PM; Boice JD
J Clin Oncol; 1996 Feb; 14(2):565-71. PubMed ID: 8636772
[TBL] [Abstract][Full Text] [Related]
38. [Lenalidomide in hematological malignancies---review].
Jin X; Zhang YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):205-9. PubMed ID: 22391198
[TBL] [Abstract][Full Text] [Related]
39. Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies.
Zuckerman E; Zuckerman T; Douer D; Qian D; Levine AM
Cancer; 1998 Sep; 83(6):1224-30. PubMed ID: 9740089
[TBL] [Abstract][Full Text] [Related]
40. [From conventional cytogenetics to microarrays. Fifty years of Philadelphia chromosome].
Hernández JM; Granada I; Solé F;
Med Clin (Barc); 2011 Jul; 137(5):221-9. PubMed ID: 20591449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
